Jump to content

Kidney transplant

From Surgopaedia

Indications

[edit | edit source]
  • End-stage renal disease (treatment of choice)
    • Refer once eGFR <30ml/min, or if dialysis expected within 12 months
    • Don't transplant until eGFR <20 and irreversible
    • Main causes in transplanted patients are diabetes, HTN, glomerulonephritis, and PCKD

Contraindications

[edit | edit source]
  • Relative
    • Age/frailty
    • IHD - MI in last 6/12 or progressive angina
    • Pulmonary disease - home oxygen, pulmonary hypertension or severe
    • Cirrhosis
    • Cerebrovascular and PVD - severe
    • History of malignancy within past five years (no need to wait for skin BCC/SCC, RCC <5cm)
  • Absolute
    • Reversible renal failure
    • Active infection or malignancy
    • Substance abuse
    • Ongoing treatment non-compliance
    • Uncontrolled psychiatric disease
    • Significantly shortened life expectancy

Initial screening

[edit | edit source]
  • History
  • Routine bloods
  • Pregnancy test
  • MMR/varicella vaccinations
  • HBV, HCV, HIV
  • TB, EBV, CMV
  • HLA/blood type
  • Drug screen
  • Urinalysis
  • CXR/ECG
  • Malignancy screening up to date

Pre-transplant nephrectomy

[edit | edit source]
  • Not routine
  • Indications:
    • Autosomal dominant polycystic kidney disease
    • Recurrent infections
    • Kidney stones

Operative - living donor

[edit | edit source]
  • Benefits
    • Increased organ availability
    • Elective surgery
    • Less immunosuppression required due to 'a good match'
    • Better long-term graft survival
  • Workup of living donor
    • Assess motivation - free of coercion, donor interviewed separately
    • Assess renal function - eGFR, must have predicted GFR >37 at age 80
    • Assess health - DM, HTN, IHD, CXR, UA etc; previous malignancy; transmissible disease
    • Cross match between donor and recipient
    • MAG3 to confirm equal kidney function
    • CTA to assess anatomy - >2 renal arteries is a relative contraindication; left kidney preferred due to longer artery
  • Technique
    • GA, CVC
    • Laparoscopic - either trans-peritoneal or sometimes retro-peritoneal
    • Open can be done too
    • Access to abdomen
    • Medialise left colon along white line to expose Gerota's
    • Incise Gerota's over kidney, and perform para-capsular dissection
    • Identify ureter at lower pole and dissect onto psoas
    • Identify and control renal vein and artery (including adrenal vein and gonadal vein on left)
    • Ligate and divide ureter
    • Remove kidney
  • Risks
    • Death 1/3000
    • Major morbidity 5%
    • GA risks
    • General risks
    • Risk of developing ESRF
    • Can develop a problem in the other kidney, but more commonly develop a problem that would have affected both kidneys
    • Damage to surrounding organs
  • Follow-up
    • Annual renal physician review for life - HTN, proteinuria, kidney function
    • Join national living donor registry

Operative - implantation

[edit | edit source]
  • Begin immunosuppression - loading dose calcineurin inhibitor
  • Assess donor kidney
    • Usually comes with cuff of aorta, cuff of IVC and ureter with periureteral tissue
  • Oblique incision just above inguinal ligament - Rutherford Morrison incision often used
  • Dissection down through EO, IO, TA with ligation of inferior epigastric vessels, and staying extra-peritoneal
  • Retroperitoneal exposure of iliac vessels via blunt dissection
  • Artery: end to side to EIA
  • Vein: end to side to EIV
  • Ureter: to bladder
  • Urine should be produced immediately. Expect diuresis. Serum creatinine slowly drops over next 3-7 days.

Complications

[edit | edit source]
  • Immediate
    • Bleeding - re-explore
    • Thrombosis of renal vessels - usually technical error, requires immediate re-exploration
    • Hyperacute rejection - presents with intra-renal thrombosis - usually straight to nephrectomy
  • Early
    • Infection
      • Wound
      • Pneumonia
      • UTI
    • Bleeding
    • Lymphocoele
      • Variable presentation - compression of vascular or ureteric structures
      • Confirm via aspiration
      • Peritoneal window may be useful to drain
    • Urine leak
      • Small leaks - nephrostomy
      • Large leaks - explore
    • Early obstruction of ureter
      • Often stent
    • Systemic complications
    • Delayed graft function
      • Dialysis required in first week
      • Exclude rejection vascular and ureteric complications
      • Dialysis required based on usual indications
  • Late
    • Vascular
      • Renal artery stenosis, or stenosis at anastomosis
        • May present with HTN
        • Treat with PTA or surgery
      • False aneurysm at anastomosis, or mycotic aneurysm
      • Late renal vein thrombosis can present with sudden-onset haematuria
    • Ureteric
      • Strictures - stent, stricturoplasty, re-implantation
      • Ischaemic strictures likely require re-operation
      • VUR
    • Immunosuppression complications
      • See separate topic
    • Malignancy
      • See separate topic
    • Graft failure
      • Rejection - see separate topic
      • Chronic allograft nephropathy - combination of chronic rejection and damage from immunosuppression
      • Return of renal disease

Presentation with graft dysfunction

[edit | edit source]
  • Less than one week post-transplant:
    • History
      • Pain
      • Urine output
    • Examination
      • Graft tenderness
      • Fluid balance
      • Ensure IDC not blocked
    • Investigations
      • Renal duplex USS - flow in vessels, ureteric obstruction
      • DTPA scan - assess perfusion
      • Renal biopsy - acute rejection
    • Causes
      • Rejection
      • Post-ischaemic ATN - especially if cold ischaemia time >24 hours or low-quality donor
      • Surgical complications - vascular thrombosis, fluid collection
    • Treatment
      • Arterial/venous thrombus or urine leak - OT
      • Normal investigations - post-ischaemia ATN - observe
      • Graft just not working very well
  • >1 week post-transplant:
    • Concern if creatinine >25% up from baseline
    • Measure tacrolimus concentration, donor-specific antibodies, CMV viral load
    • Approach:
      • If high index of suspicion for rejection -> biopsy
      • Elevate tac level -> reduce the dose

Prognosis

[edit | edit source]
  • 5-year graft survival
    • Living donor 90%
    • Deceased donor 81%